Skip to main content
Health Science Reports logoLink to Health Science Reports
. 2025 Sep 26;8(10):e71295. doi: 10.1002/hsr2.71295

Predicting the Determinants of Colorectal Cancer Screening Behaviors Using Protection Motivation Theory: A Cross‐Sectional Partial Least Squares Structural Equation Modeling Analysis

Mahdi Gholian‐Aval 1,2, Bahareh Behrouzi 3, Jamshid Jamali 1,4,
PMCID: PMC12464729  PMID: 41017861

ABSTRACT

Background

Colorectal cancer (CRC) screening reduces mortality by 40%–60%, yet participation remains low globally. In this study, we applied protection motivation theory (PMT) to identify determinants of CRC screening behavior in Iran using partial least squares structural equation modeling (PLS‐SEM).

Design and Methods

This cross‐sectional study was conducted on 433 adults over 50 years of age using stratified sampling in Neyshabur, Iran in 2024. Participants completed a validated 43‐item PMT questionnaire assessing key cognitive factors (perceived sensitivity, severity, self‐efficacy, response efficacy, response costs, fear, rewards, and behavioral intention), with self‐reported screening behavior as the outcome.

Results

Among the PMT constructs, self‐efficacy had the highest mean score (69.43 ± 18.97 out of 100), while actual screening behavior had the lowest (26.12 ± 9.93 out of 100). PLS‐SEM analysis revealed significant pathways: perceived severity (β = 0.118, p = 0.030) and response efficacy (β = 0.172, p = 0.003) positively influenced behavioral intention, while perceived rewards negatively impacted intention (β = −0.197, p < 0.001). Fear mediated sensitivity/severity effects on intention (β = 0.155, p = 0.003). Notably, self‐efficacy and response costs showed nonsignificant relationships with intention.

Conclusion

Participants demonstrated moderate intention (54.8 of 100) yet low screening behavior (26.1 of 100), highlighting a critical intention–behavior gap. While PMT constructs effectively predicted screening intention, their limited ability to explain behavior underscores the influence of contextual barriers beyond cognitive appraisals in this Iranian cohort. Future interventions should integrate PMT‐based education targeting threat appraisal with system‐level strategies (e.g., mailed test kits, navigational support) to bridge this implementation gap.

Keywords: colorectal cancer, Iran, partial least squares, protection motivation theory, screening, structural equation modeling


Abbreviations

CRC

colorectal cancer

PMT

protection motivation theory

PLS‐SEM

partial least squares structural equation modeling

FIT

fecal immunochemical tests

1. Introduction

Colorectal cancer (CRC) represents one of the most prevalent and lethal malignancies globally, imposing a substantial burden on healthcare systems and accounting for millions of deaths annually [1]. Robust evidence indicates that early detection through regular screening can significantly reduce CRC mortality by approximately 40%–60% [2]. Despite this proven effectiveness, participation rates in CRC screening programs remain suboptimal in many populations [3]. This underscores the critical need for a deeper understanding of the psychological, social, and demographic determinants of screening behaviors as a research and public health priority [4].

Protection motivation theory (PMT) offers a robust framework for understanding preventive health behaviors, including cancer screening, with core constructs of threat appraisal (severity and perceived sensitivity, balanced against maladaptive rewards) and coping appraisal (response efficacy, self‐efficacy, and perceived barriers or response costs) [5, 6, 7, 8, 9, 10, 11]. Norman et al. and other studies support PMT's usefulness in predicting cancer screening intentions and behaviors, highlighting self‐efficacy and perceived severity as key predictors [7, 12, 13, 14, 15, 16].

In the context of CRC screening, PMT posits higher likelihood of participation when individuals view CRC as a severe personal threat (high perceived severity and sensitivity), believe screening reduces risk (high response efficacy), and feel capable of completing the process (high self‐efficacy), while greater barriers and rewards of inaction can reduce motivation [8, 9, 10, 11, 17, 18, 19]. Consequently, PMT has guided interventions to boost screening uptake by enhancing threat perceptions, strengthening coping appraisals (clarifying benefits, building self‐efficacy), and addressing barriers [10, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29]. Evidence suggests PMT‐based interventions that focus on knowledge and barriers can raise screening participation, with self‐efficacy and response efficacy consistently predicting screening intentions across populations [9, 26].

Analyzing the complex, multilevel relationships between latent PMT constructs (e.g., perceived severity, sensitivity, self‐efficacy, response efficacy, and response costs) and actual screening behavior requires advanced multivariate methods like structural equation modeling (SEM) [30]. Within SEM, two primary approaches exist: covariance‐based SEM (CB‐SEM) and partial least squares SEM (PLS‐SEM) [30]. CB‐SEM is ideal for confirming complex causal theories, assuming multivariate normality and larger sample sizes. PLS‐SEM, however, offers greater flexibility, being robust to violations of distributional assumptions, suitable for smaller samples, and focused on maximizing variance explained in dependent variables (prediction) [30, 31].

Comparative studies, such as Hair et al., indicate PLS‐SEM often performs better under non‐normal data or smaller sample conditions, while CB‐SEM excels in rigorous causal theory testing under ideal conditions [30]. PLS‐SEM has also proven effective in modeling complex predictors of health behaviors, including screening [32].

Despite numerous studies applying PMT to understand CRC screening behaviors, the specific use of PLS‐SEM for predicting CRC screening determinants within the PMT framework remains underexplored. This gap may lead researchers to select analytical methods less suited to their data characteristics or predictive goals.

Therefore, this study aims to address this gap by evaluating the performance of PLS‐SEM in predicting determinants of CRC screening behavior based on PMT. This study is significant for several reasons: First, by potentially identifying key PMT predictors of CRC screening behavior more accurately, it can inform the design of more effective interventions to increase participation. Second, by rigorously applying PLS‐SEM in a health context, it provides clearer guidance for researchers on selecting the appropriate SEM approach (CB‐SEM for theory confirmation vs. PLS‐SEM for prediction) based on data characteristics and research objectives. Third, it contributes to the methodological and theoretical literature on cancer prevention by integrating PMT with advanced analytical techniques.

2. Methods

This cross‐sectional study will be conducted in 2024 among adults aged ≥ 50 years residing in Neyshabur, the second‐largest city in Khorasan Razavi Province, Iran, with an estimated population of 300,000. Inclusion criteria comprised willingness to participate, ability to comprehend and respond to the questionnaire, adequate literacy, and no personal history of CRC. Participants completing less than 50% of the questionnaire were excluded. A stratified sampling method with proportional allocation was employed. First, Neyshabur was divided into 11 strata corresponding to its comprehensive health centers. Participants were then systematically selected from each stratum proportionate to its population size. The sample size was calculated based on recommendations for partial least squares structural equation modeling (PLS‐SEM), requiring 5–10 participants per questionnaire item and a minimum of 300 participants [33]. The questionnaire contained 43 items (39 measuring PMT constructs and 4 assessing behavior), leading to a minimum target sample size of 430; ultimately, 433 participants completed the survey.

Data were collected using a validated PMT questionnaire [26]. This instrument measures eight latent constructs: perceived sensitivity (four items, Cronbach's α = 0.91), perceived severity (seven items, α = 0.88), fear (four items, α = 0.70), perceived reward (three items, α = 0.83), response efficacy (six items, α = 0.79), self‐efficacy (six items, α = 0.89), response cost (six items, α = 0.74), and behavioral intention (three items, α = 0.93). All items for these constructs used a 5‐point Likert scale (1 = strongly disagree to 5 = strongly agree). Actual CRC screening behavior was assessed using four separate dichotomous (yes/no) items. The study received ethical approval from the Regional Ethics Committee of Mashhad University of Medical Sciences (IR.MUMS.FHMPM.REC.1404.030), and written informed consent was obtained from all participants before enrollment. All study procedures complied with the principles of the Declaration of Helsinki and applicable institutional guidelines.

PLS‐SEM was used to analyze the relationships between PMT constructs and CRC screening behavior. This method was selected due to its suitability for predictive and exploratory research, flexibility with non‐normal data distributions and smaller sample sizes, and primary focus on maximizing explained variance in the dependent variables [31, 34]. Cohen's f² was used to assess the effect size of the model. f² values of 0.02–0.15 indicate a small effect, 0.15–0.35 a medium effect, and ≥ 0.35 a large effect on the dependent variable [35]. The coefficient of determination, R², was used to estimate the proportion of variance in the dependent variables explained by the model. R² values are interpreted as follows: < 0.19 = very weak; 0.19–0.33 = weak; 0.33–0.67 = moderate; ≥ 0.67 = substantial [36]. In this study, all participants responded to every item in the questionnaires, and there were no missing data in the questionnaires; analyses were conducted using complete data. Analyses were performed using SmartPLS software (version 4.0) [31]. The statistical significance level was set at α = 0.10 for Full PLS‐SEM and α = 0.05 for all other hypothesis tests. All statistical tests were conducted two‐sided.

3. Results

The study included 433 participants with a mean age of 58.26 ± 5.41 years. The majority were female (61.9%, n = 268), married (72.3%, n = 313), had three to five children (55.2%, n = 239), possessed less than a high school diploma (45.3%, n = 196), and identified as housewives (43.2%, n = 187). Detailed demographic characteristics are presented in Table 1.

Table 1.

Demographic characteristics of participants (n = 433).

Characteristic Category Number %
Gender Female 268 61.9
Male 165 38.1
Marital status Single 5 1.2
Married 313 72.3
Divorced 17 3.9
Widowed 98 22.6
Number of children No children 12 2.8
1–2 children 128 29.6
3–5 children 239 55.2
> 5 children 54 12.5
Educational level Illiterate 92 21.2
< High school diploma 196 45.3
High school diploma 116 26.8
University education 29 6.7
Occupation Worker 47 10.9
Employee 35 8.1
Freelance 85 19.6
Housewife 187 43.2
Retired 64 14.8
Unemployed 4 0.9
Farmer 11 2.5

Among the PMT constructs, self‐efficacy exhibited the highest mean score (69.43 ± 18.97), while the lowest score was observed for the actual screening behavior construct (26.12 ± 9.93). Scores for all constructs, standardized to a 0–100 scale, are detailed in Table 2.

Table 2.

Scores of PMT constructs (standardized to 0–100 scale).

Construct Mean ± standard deviation Median (first quartile, third quartile)
Perceived sensitivity 41.86 ± 13.6 43.75 (31.25, 50.00)
Perceived severity 66.48 ± 20.22 67.86 (53.57, 78.57)
Fear 45.71 ± 18.72 43.75 (31.25, 56.25)
Perceived reward 42.71 ± 21.48 41.67 (25.00, 58.33)
Response effectiveness 67.72 ± 17.84 66.67 (54.17, 79.17)
Self‐efficacy 69.43 ± 18.97 70.83 (54.17, 79.17)
Response cost 39.23 ± 18.86 37.50 (25.00, 50.00)
Behavioral intention 54.83 ± 18.28 50.00 (50.00, 66.67)
Behavior 9.93 ± 26.12 0.00 (0.00, 0.00)

Initial PLS‐SEM analysis fitting the full PMT model revealed Nonsignificant paths (p > 0.05) from response cost (β = −0.011, p = 0.988), self‐efficacy (β = 0.054, p = 0.396), and perceived sensitivity (β = −0.011, p = 0.843) to behavioral intention (Table 3, Figure 1). Consequently, these paths were removed, and a refined model was fitted (Figure 2, Table 4).

Table 3.

PLS‐SEM path coefficients—full PMT model.

Path β ± SE t value (p value) f 2
Behavioral intention → Behavior 0.063 ± 0.016 3.818 (< 0.001) 0.041
Fear → Behavioral intention 0.152 ± 0.055 2.797 (0.005) 0.023
Perceived reward → Behavioral intention −0.176 ± 0.056 3.173 (0.002) 0.001
Perceived sensitivity → Behavioral intention −0.011 ± 0.053 0.198 (0.843) 0.009
Perceived sensitivity → Fear 0.293 ± 0.057 5.066 (< 0.001) 0.088
Perceived severity → Behavioral intention 0.109 ± 0.06 1.82 (0.069) 0.009
Perceived severity → Fear 0.254 ± 0.053 4.783 (< 0.001) 0.068
Response cost → Behavioral intention −0.011 ± 0.067 0.015 (0.988) 0.001
Response effectiveness → Behavioral intention 0.159 ± 0.06 2.64 (0.008) 0.020
Self‐efficacy → Behavioral intention 0.054 ± 0.067 0.848 (0.396) 0.002

Note: Bolded values are nonsignificant paths at the 0.05 level and were removed in the refined PMT model.

Abbreviations: β, standardized regression coefficient; SE, standard error of the parameter estimate.

Figure 1.

Figure 1

Full PLS‐SEM fitting based on the full model of PMT. The numbers on the paths represent regression coefficients and associated p‐values, while the numbers within the constructs denote the coefficients of determination (R²).

Figure 2.

Figure 2

PLS‐SEM fitting based on the modified model of PMT after removing nonsignificant paths. The numbers on the paths represent regression coefficients and associated p‐values, while the numbers within the constructs denote the coefficients of determination (R²).

Table 4.

PLS‐SEM path coefficients—refined PMT model (nonsignificant paths removed).

Path β ± SE t value (p value) f 2
Behavioral intention → Behavior 0.063 ± 0.016 3.815 (< 0.001) 0.041
Fear → Behavioral intention 0.155 ± 0.052 2.986 (0.003) 0.026
Perceived reward → Behavioral intention −0.197 ± 0.049 3.971 (< 0.001) 0.038
Perceived sensitivity → Fear 0.294 ± 0.057 5.106 (< 0.001) 0.088
Perceived severity → Behavioral intention 0.118 ± 0.054 2.172 (0.030) 0.012
Perceived severity → Fear 0.254 ± 0.053 4.795 (< 0.001) 0.068
Response effectiveness → Behavioral intention 0.172 ± 0.057 2.993 (0.003) 0.024

Abbreviations: β, standardized regression coefficient; SE, standard error of the parameter estimate.

The refined model explained 20.5% of the variance in fear (R² = 0.205), 22.0% of the variance in behavioral intention (R² = 0.220), and 3.9% of the variance in actual screening behavior (R² = 0.039).

4. Discussion and Conclusion

The present study revealed a pronounced intention–behavior gap in CRC screening, with PMT constructs explaining only 3.9% of the variance in actual screening behavior, despite accounting for 22.0% of the behavioral intention. This substantial discrepancy between intention formation and behavioral execution aligns with findings from Wuhan, China, where PMT constructs predicted 24% of screening intention, but actual behavior was not measured [9]. This suggests a fundamental limitation in translating cognitive appraisals into preventive action. The low uptake of screening (mean score 26.12/100) contrasts sharply with high self‐efficacy scores (69.43/100), potentially indicating social desirability bias in self‐reported measures—a methodological limitation noted in multiple PMT studies [37]. This bias could be mitigated through objective verification using electronic health records, as implemented in Kaiser Permanente's research programs [38].

Notably, self‐efficacy (β = 0.054, p = 0.396) and response costs (β = −0.011, p = 0.988) demonstrated nonsignificant relationships with behavioral intention, contradicting global PMT literature where these factors are typically strong predictors [39]. This divergence may reflect the contextual specificities of Iran's fragmented healthcare system, where structural barriers potentially overshadow individual confidence. Conversely, urban Chinese populations have shown self‐efficacy as a dominant predictor (β = 0.36, p < 0.01) [9], while studies from Saudi Arabia identify response costs—such as procedural discomfort and privacy concerns—as primary deterrents [40]. The prominence of fear (β = 0.155, p = 0.003) and response efficacy (β = 0.172, p = 0.003) as key drivers of intention in our study echoes qualitative findings from Saudi populations [40], where awareness of cancer severity motivated screening consideration despite procedural fears.

The observed positive effect of fear on behavioral intention (β = 0.155, p = 0.003) aligns with contemporary refinements of PMT, which posit that fear enhances motivation when individuals perceive high self‐efficacy and response efficacy; conditions present in our study [41]. This counters classic views of fear‐induced avoidance by demonstrating its adaptive potential in health contexts where threat appraisals are coupled with strong coping appraisals [42]. Specifically, in cancer screening behaviors, fear functions as a mediator that translates perceived susceptibility and severity into protective intention when cultural frameworks (e.g., viewing cancer as a “stealth enemy”) amplify the perceived value of vigilance [43, 44]. Thus, our findings reflect a context‐dependent manifestation of PMT principles rather than a theoretical paradox [39].

Methodologically, the application of PLS‐SEM was justified by the nonnormal data distribution and moderate sample size (N = 433), consistent with recommendations for predictive modeling in health behavior research [45]. This approach proved advantageous over covariance‐based SEM for our exploratory aims, as demonstrated in other CRC screening studies [1]. However, the exceedingly low explained variance for actual behavior (R² = 0.039) underscores potential measurement limitations in operationalizing this construct via self‐reported dichotomous items, highlighting the need for future studies to incorporate multimodal assessments, such as medical record verification [38].

The sociodemographic profile—predominantly female (61.9%) and low educational attainment (66.5% with less than a high school diploma)—reflects gendered healthcare engagement patterns and literacy barriers documented in Middle Eastern cancer screening literature [40]. These findings resonate with Saudi studies identifying female‐specific barriers [40] and mirror socioeconomic gradients observed in American Indian communities, where education level and trust in providers significantly influence screening participation [46]. Iran's opportunistic screening approach starkly contrasts with Korea's National Cancer Screening Program, which achieved a 45.5% colonoscopy uptake through systematic invitations and subsidized services [47]. This comparison suggests that environmental enablers are likely prerequisites for PMT constructs to effectively translate into action.

This study possesses several strengths. First, the employment of PLS‐SEM was appropriate given the focus on predictive accuracy rather than theory confirmation and considering the moderate sample size (n = 433). PLS‐SEM's robustness in managing non‐normal data distributions and complex latent variables is well established in health behavior research [31]. Second, the stratified sampling across 11 health districts in Neyshabur, Iran, enhanced the representativeness of the sample. The sample size exceeded the minimum requirement—based on the rule of 5–10 participants per questionnaire item—aligning with Kass and Tinsley's guidelines [33]. Such methodological rigor addresses gaps in applying PMT within underrepresented populations, contrasting with prior research predominantly conducted in Western or East Asian contexts [9]. The significant predictors—response efficacy (β = 0.172, p = 0.003) and perceived severity (β = 0.118, p = 0.030)—are consistent with global PMT findings. A culturally specific finding of note was the lack of significance of self‐efficacy, diverging from results in urban Chinese populations [9].

Empirical work across health behaviors suggests that contextual factors—such as access to care, health system navigation, social norms, and logistical barriers—can reshape threat and coping appraisals and, in turn, behavioral outcomes (e.g., cancer screening uptake) beyond individual cognitions alone. Integrating PMT with models that account for environmental and policy‐level influences has shown promise in improving explanatory power and informing multilevel interventions. For instance, frameworks that combine health behavior theory with social ecological considerations have yielded stronger associations with preventive behaviors and guided more effective implementation strategies in population health research published in high‐impact journals. Future work in this domain could operationalize an integrated model by adding measurable environmental/structural constructs (e.g., access to screening, reminder systems, transportation, and system navigation) to PMT, enabling more precise identification of leverage points for policy and programmatic interventions [48, 49, 50].

The large gap between intention and action (44.9 points) in this study can be explained by structural barriers in resource‐limited settings, especially in low‐ and middle‐income countries [51, 52, 53]. Structural barriers may overshadow individual psychological factors in preventing action [54]. PMT explains how intentions form but not how they lead to action [39]; the Health Action Process Approach suggests that planned actions (like action planning) help turn intentions into behavior [55]. This is supported by the weak link between self‐efficacy and behavioral intention in our data (β = 0.054). Psychological factors such as procrastination seem to interact with systemic barriers, indicating that individual‐focused interventions (e.g., planning tools) must be paired with structural changes to reduce barriers to action [56].

Like other studies, this study has limitations. The cross‐sectional design restricts causal inference regarding the relationships between PMT constructs and behaviors. Furthermore, the very low variance explained in actual screening behavior (R² = 0.039), despite a relatively higher explanation of intention (22.0%), illustrates a persistent intention‐behavior gap—a challenge frequently encountered in CRC screening research [9, 57]. Reliance on self‐reported, dichotomous behavioral measures may have introduced social desirability bias, explaining the discrepancy between high self‐efficacy scores and low actual screening rates. Another limitation of this study was measuring behavior as a dichotomous outcome (yes/no). It is suggested that future research consider objective or continuous criteria for screening behavior. This study focused on PMT; future research should compare PMT with alternative models, such as the health belief model (HBM).

Future research should employ longitudinal designs to clarify how PMT constructs influence behavior over time, as demonstrated in Korea's National Cancer Screening Program evaluations [47, 58]. Incorporating system‐level variables—such as healthcare accessibility and provider recommendations—may enhance predictive accuracy. Additionally, replicating PMT analyses across diverse populations, including rural and underserved groups, can improve generalizability. Tailored interventions are also critical; for example, community navigator programs to bolster self‐efficacy, modeled after successful initiatives within U.S. American Indian populations, could be adapted for the Iranian context. It is also valuable to compare PMT's utility with other frameworks, such as the HBM, particularly in regions with organized screening programs (e.g., the Netherlands), versus opportunistic systems [59].

Finally, evaluating the cost‐effectiveness of PMT‐based interventions—like educational campaigns versus mailed fecal immunochemical tests (FIT)—would inform policy choices and resource allocation. A comprehensive approach integrating behavioral theory with system‐level modifications holds promise for improving screening uptake globally.

5. Implications for Practice

Our findings support targeted messaging emphasizing perceived severity and response efficacy, which are significant predictors of intention. For instance, PMT‐based educational campaigns that highlight screening effectiveness successfully increased FIT participation in Iran, yielding an 18.6% uptake increase [10]. However, addressing the weak translation from intention to behavior necessitates multilevel strategies: individual‐level navigational support to overcome self‐efficacy barriers, system‐level interventions like mailed FIT kits [38], and community engagement to change cultural perceptions [46]. Iran can transform opportunistic screening into proactive prevention by embedding mailed FIT within Primary Healthcare Centers systems and budget allocation. Early pilots show 40%–71.7% participation is feasible, with colonoscopy access as the critical scalability determinant [60, 61, 62]. Future research that combines longitudinal tracking of multiple factors, utilizes objective behavioral assessments, and tests integrated models—including healthcare access variables—could better elucidate the complex interplay of determinants influencing CRC screening behaviors across diverse settings.

Author Contributions

Mahdi Gholian‐Aval: conceptualization, writing – review and editing. Bahareh Behrouzi: conceptualization, supervision, writing – original draft. Jamshid Jamali: data curation, writing – review and editing. All authors participated in drafting the manuscript and approved the final version.

Conflicts of Interest

The authors declare no conflicts of interest.

Transparency Statement

The lead author Jamshid Jamali affirms that this manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained.

Acknowledgments

The authors wish to thank all participants for their contribution to this study. We also extend our gratitude to Dr. Hadi Tehrani for his assistance in interpreting some of the results. Support was provided internally by the Deputy of Research at Mashhad University of Medical Sciences (Project No. 4032278).

Data Availability Statement

The data produced and examined in this study can be obtained from the corresponding author upon a reasonable request, contingent upon approval from the Mashhad Regional Committee for Medical Research Ethics.

References

  • 1. Bray F., Ferlay J., Soerjomataram I., Siegel R. L., Torre L. A., and Jemal A., “Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries,” CA: A Cancer Journal for Clinicians 68, no. 6 (2018): 394–424. [DOI] [PubMed] [Google Scholar]
  • 2. Zauber A. G., Winawer S. J., O'Brien M. J., et al., “Colonoscopic Polypectomy and Long‐Term Prevention of Colorectal‐Cancer Deaths,” New England Journal of Medicine 366, no. 8 (2012): 687–696. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Issaka R. B., Avila P., Whitaker E., Bent S., and Somsouk M., “Population Health Interventions to Improve Colorectal Cancer Screening by Fecal Immunochemical Tests: A Systematic Review,” Preventive Medicine 118 (2019): 113–121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Wools A., Dapper E. A., and Leeuw J. R. J., “Colorectal Cancer Screening Participation: A Systematic Review,” European Journal of Public Health 26, no. 1 (2016): 158–168. [DOI] [PubMed] [Google Scholar]
  • 5. Rogers R. W., “A Protection Motivation Theory of Fear Appeals and Attitude Change1,” Journal of Psychology 91, no. 1 (1975): 93–114. [DOI] [PubMed] [Google Scholar]
  • 6. Floyd D. L., Prentice‐Dunn S., and Rogers R. W., “A Meta‐Analysis of Research on Protection Motivation Theory,” Journal of Applied Social Psychology 30, no. 2 (2000): 407–429. [Google Scholar]
  • 7. Norman P., Boer H., and Seydel E. R., “Protection Motivation Theory,” in Predicting Health Behaviour: Research and Practice With Social Cognition Models, eds. Conner M. and Norman P. (Open University Press, 2005), 81–126. [Google Scholar]
  • 8. Babazadeh T., Nadrian H., Banayejeddi M., and Rezapour B., “Determinants of Skin Cancer Preventive Behaviors Among Rural Farmers in Iran: An Application of Protection Motivation Theory,” Journal of Cancer Education 32, no. 3 (2017): 604–612. [DOI] [PubMed] [Google Scholar]
  • 9. Wei W., Zhang M., Zuo D., et al., “Screening Intention Prediction of Colorectal Cancer Among Urban Chinese Based on the Protection Motivation Theory,” International Journal of Environmental Research and Public Health 19, no. 7 (2022): 4203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Hajizadeh M., Moshki M., Khajavian N., and Dogonchi M., “Effect of Educational Intervention Based on Motivational Protection Theory on Colorectal Cancer Screening Behaviors of Middle‐Aged Adults Aged 45 to 55 in Eastern Iran,” Iranian Journal of Health Education and Health Promotion 13, no. 2 (2025): 160–172. [Google Scholar]
  • 11. Rahaei Z., Ghofranipour F., Morowatisharifabad M., and Mohammadi E., “Determinants of Cancer Early Detection Behaviors: Application of Protection Motivation Theory,” Health Promotion Perspectives 5, no. 2 (2015): 138–146. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Atkinson T. M., Salz T., Touza K. K., Li Y., and Hay J. L., “Does Colorectal Cancer Risk Perception Predict Screening Behavior? A Systematic Review and Meta‐Analysis,” Journal of Behavioral Medicine 38, no. 6 (2015): 837–850. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Neil J. M., Parker N. D., Levites Strekalova Y. A., Duke K., George T., and Krieger J. L., “Communicating Risk to Promote Colorectal Cancer Screening: A Multi‐Method Study to Test Tailored Versus Targeted Message Strategies,” Health Education Research 37, no. 2 (2022): 79–93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Pengchit W., Walters S. T., Simmons R. G., et al., “Motivation‐Based Intervention to Promote Colonoscopy Screening: An Integration of a Fear Management Model and Motivational Interviewing,” Journal of Health Psychology 16, no. 8 (2011): 1187–1197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Douma L. N., Uiters E., Verweij M. F., and Timmermans D. R. M., “Autonomous and Informed Decision‐Making: The Case of Colorectal Cancer Screening,” PLoS One 15, no. 5 (2020): e0233308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Lo S. H., Waller J., Wardle J., and von Wagner C., “Comparing Barriers to Colorectal Cancer Screening With Barriers to Breast and Cervical Screening: A Population‐Based Survey of Screening‐Age Women in Great Britain,” Journal of Medical Screening 20, no. 2 (2013): 73–79. [DOI] [PubMed] [Google Scholar]
  • 17. Goodman M., Fletcher R. H., Doria‐Rose V. P., et al., “Observational Methods to Assess the Effectiveness of Screening Colonoscopy in Reducing Right Colon Cancer Mortality Risk: SCOLAR,” Journal of Comparative Effectiveness Research 4, no. 6 (2015): 541–551. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Wang L., Liu C., Wang Y., and Du L., “Cost‐Effectiveness of Risk‐Tailored Screening Strategy for Colorectal Cancer: A Systematic Review,” Journal of Gastroenterology and Hepatology 37, no. 7 (2022): 1235–1243. [DOI] [PubMed] [Google Scholar]
  • 19. Davis T. C., Morris J., Rademaker A., Ferguson L. A., and Arnold C. L., “Barriers and Facilitators to Colorectal Cancer Screening Among Rural Women in Community Clinics by Heath Literacy,” Journal of Womens Health, Issues and Care 6, no. 6 (2017): 1000292, https://pubmed.ncbi.nlm.nih.gov/29568788/. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Walsh J., “Colorectal Cancer Screening. The Time Is Now!,” Journal of General Internal Medicine 20, no. 11 (2005): 1068–1070. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Percac‐Lima S., Grant R. W., Green A. R., et al., “A Culturally Tailored Navigator Program for Colorectal Cancer Screening in a Community Health Center: A Randomized, Controlled Trial,” Journal of General Internal Medicine 24, no. 2 (2009): 211–217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Reddy A. C. and Chui M. A., “Using Protection Motivation Theory to Develop a Survey of Over‐the‐Counter Decision‐Making by Older Adults,” Research in Social and Administrative Pharmacy 20, no. 1 (2024): 10–18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Boonyasiriwat W., Hung M., Hon S. D., et al., “Intention to Undergo Colonoscopy Screening Among Relatives of Colorectal Cancer Cases: A Theory‐Based Model,” Annals of Behavioral Medicine 47, no. 3 (2014): 280–291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Ma G. X., Zhu L., Tan Y., et al., “Multilevel and Multicomponent Intervention to Promote Colorectal Cancer Screening Among Underserved Vietnamese Americans: A Cluster Randomized Trial,” preprint, Res Sq, February 8, 2024, https://pubmed.ncbi.nlm.nih.gov/38405822/.
  • 25. Williams R. M., Wilkerson T., and Holt C. L., “The Role of Perceived Benefits and Barriers in Colorectal Cancer Screening in Intervention Trials Among African Americans,” Health Education Research 33, no. 3 (2018): 205–217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Emadi Azam M., Bashirian S., Shahanjarini A. K., and Barati M., “Factors Associated With Intention to Perform Fecal Occult Blood Test Among Medical Professionals: An Application of the Protection Motivation Theory,” Govaresh 24, no. 3 (2019): 9. [Google Scholar]
  • 27. Honda K. and Gorin S. S., “Modeling Pathways to Affective Barriers on Colorectal Cancer Screening Among Japanese Americans,” Journal of Behavioral Medicine 28, no. 2 (2005): 115–124. [DOI] [PubMed] [Google Scholar]
  • 28. Emerson B., Reiter P. L., Klatt M., et al., “Development of a Brief Online Mindfulness‐Based Intervention to Reduce Patient Anxiety Before a First‐Time Screening Colonoscopy,” Journal of Cancer Education, ahead of print, March 31, 2025, https://pubmed.ncbi.nlm.nih.gov/40163313/. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Fakkiew S., Teravecharoenchai S., Khemtong P., and Suksatan W., “Impact of a Health Promotion Program on Knowledge, Physical Health, Mental Health, and Social Health Behaviors in Individuals at Risk for Colorectal Cancer,” Societies 14, no. 9 (2024): 182. [Google Scholar]
  • 30. Hair J. F. Jr., Hult G. T. M., Ringle C. M., and Sarstedt M., A Primer on Partial Least Squares Structural Equation Modeling (PLS‐SEM) (Sage Publications, 2017). [Google Scholar]
  • 31. Henseler J., Hubona G., and Ray P. A., “Using PLS Path Modeling in New Technology Research: Updated Guidelines,” Industrial Management & Data Systems 116, no. 1 (2016): 2–20. [Google Scholar]
  • 32. Ringle C. M., Sarstedt M., and Straub D. W., “Editor's Comments: A Critical Look at the Use of PLS‐SEM in ‘MIS Quarterly’,” MIS Quarterly 36, no. 1 (2012): iii–xiv. [Google Scholar]
  • 33. Kass R. A. and Tinsley H. E. A., “Factor Analysis,” Journal of Leisure Research 11 (1979): 120–138. [Google Scholar]
  • 34. Benitez J., Henseler J., Castillo A., and Schuberth F., “How to Perform and Report an Impactful Analysis Using Partial Least Squares: Guidelines for Confirmatory and Explanatory IS Research,” Information & Management 57, no. 2 (2020): 103168. [Google Scholar]
  • 35. Cohen J. E., Statistical Power Analysis for the Behavioral Sciences (Lawrence Erlbaum Associates, Inc., 1988). [Google Scholar]
  • 36. Chin W. W., “The Partial Least Squares Approach for Structural Equation Modeling,” in Modern Methods for Business Research, ed. Marcoulides G. A. (Lawrence Erlbaum Associates Publishers, 1998), 295–336. [Google Scholar]
  • 37. Champion V. L. and Skinner C. S., “The Health Belief Model”, in Health Behavior and Health Education: Theory, Research, and Practice (Jossey‐Bass/Wiley, 2008), 45–65. [Google Scholar]
  • 38. Levin T. R., Corley D. A., Jensen C. D., et al., “Effects of Organized Colorectal Cancer Screening on Cancer Incidence and Mortality in a Large Community‐Based Population,” Gastroenterology 155, no. 5 (2018): 1383–1391.e5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Rogers R. W., “Cognitive and Physiological Processes in Fear Appeals and Attitude Change: A Revised Theory of Protection Motivation,” in Social Psychology: A Source Book, eds. Cacioppo J. and Petty R. (Guilford Press, 1983), 153–176. [Google Scholar]
  • 40. Mohammed A., Alawaji M. A., Alharbi A. B., et al., “Assessment of Knowledge and Barriers to Colon Cancer Screening Among the General Public in the Qassim Region,” Cureus 17, no. 4 (2025): e82047. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Witte K., “Putting the Fear Back Into Fear Appeals: The Extended Parallel Process Model,” Communication Monographs 59, no. 4 (1992): 329–349. [Google Scholar]
  • 42. Milne S., Sheeran P., and Orbell S., “Prediction and Intervention in Health‐Related Behavior: A Meta‐Analytic Review of Protection Motivation Theory,” Journal of Applied Social Psychology 30, no. 1 (2000): 106–143. [Google Scholar]
  • 43. Vrinten C., McGregor L. M., Heinrich M., et al., “What Do People Fear About Cancer? A Systematic Review and Meta‐Synthesis of Cancer Fears in the General Population,” Psycho‐Oncology 26, no. 8 (2016): 1070–1079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Londoudi A., Skampardonis K., Alikari V., et al., “Assessment of the Relationship Between Fear of Cancer Recurrence, Spiritual Well‐Being, and Mental Health Among Cancer Patients: A Cross‐Sectional Study,” Nursing Reports 14, no. 1 (2024): 317–327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Hair J. F., Risher J. J., Sarstedt M., and Ringle C. M., “When to Use and How to Report the Results of PLS‐SEM,” European Business Review 31, no. 1 (2019): 2–24. [Google Scholar]
  • 46. Adsul P., Kanabar N., Rodman J., et al., “Multilevel Socioecological Determinants of Colorectal Cancer Screening Among American Indian Communities in New Mexico,” Cancer Causes & Control 36 (2025): 965–978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47. Lee H. J., Lee K., Kim B. C., Jun J. K., Choi K. S., and Suh M., “Effectiveness of the Korean National Cancer Screening Program in Reducing Colorectal Cancer Mortality,” Cancers 16, no. 24 (2024): 4278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.K. Glanz, B. K. Rimer, and K. V. Viswanath, eds., Theory, Research, and Practice in Health Behavior,” in Health Behavior: Theory, Research, and Practice (Jossey‐Bass/Wiley, 2015), 23–41.
  • 49. Sallis J. F., Owen N., and Fisher E. B., “Ecological Models of Health Behavior,” in Health Behavior and Health Education: Theory, Research, and Practice, eds. Glanz K., Rimer B. K., and Viswanath K. V. (Jossey‐Bass, 2008), 465–486. [Google Scholar]
  • 50. Schwarzer R. and Fuchs R., “Self‐Efficacy and Health Behaviours,” in Predicting Health Behaviour: Research and Practice with Social Cognition Models, eds. Conner M. and Norman P. (Open University Press, 1995), 163–196. [Google Scholar]
  • 51. Kamarajah S., Ismail L., Ademuyiwa A., et al., “Mechanisms and Causes of Death After Abdominal Surgery in Low‐Income and Middle‐Income Countries: A Secondary Analysis of the FALCON Trial,” Lancet Global Health 12, no. 11 (2024): e1807–e1815. [DOI] [PubMed] [Google Scholar]
  • 52. Mabaso B., Osakwe C. N., and Jibril A. B., “Exploring the Green Purchase Intention‐Behavior Gap Among South African Millennials Using an Expanded Planned Behavior Model,” Cogent Business & Management 12, no. 1 (2025): 2538715. [Google Scholar]
  • 53. Zhou Y., Wei B., Zhang R., Zhang L., Zhu H., and Wen T., “Narrowing the Gap Between Intention and Behavior? An Empirical Study of Farmers’ Waste Classification in China,” Frontiers in Environmental Science 11 (2023): 1045816. [Google Scholar]
  • 54. Islam R. M., Billah B., Hossain M. N., and Oldroyd J., “Barriers to Cervical Cancer and Breast Cancer Screening Uptake in Low‐Income and Middle‐Income Countries: A Systematic Review,” Asian Pacific Journal of Cancer Prevention 18, no. 7 (2017): 1751–1763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55. Schwarzer R., “Modeling Health Behavior Change: How to Predict and Modify the Adoption and Maintenance of Health Behaviors,” Applied Psychology 57, no. 1 (2008): 1–29. [Google Scholar]
  • 56. Kiviniemi M. T., Bennett A., Zaiter M., and Marshall J. R., “Individual‐Level Factors in Colorectal Cancer Screening: A Review of the Literature on the Relation of Individual‐Level Health Behavior Constructs and Screening Behavior,” Psycho‐Oncology 20, no. 10 (2011): 1023–1033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57. Miller Wilson L. A., Browne S., Barnes J., et al., “Opportunities and Challenges in Screening for Colorectal Cancer,” Population Health Management 26, no. 4 (2023): 246–253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58. Lee K., Seo H., Choe S., et al., “Intentions to Undergo Primary Screening With Colonoscopy under the National Cancer Screening Program in Korea,” PLoS One 16, no. 2 (2021): e0247252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59. Wisse P. H. A., de Klaver W., van Wifferen F., et al., “The Multitarget Faecal Immunochemical Test for Improving Stool‐Based Colorectal Cancer Screening Programmes: A Dutch Population‐Based, Paired‐Design, Intervention Study,” Lancet Oncology 25, no. 3 (2024): 326–337. [DOI] [PubMed] [Google Scholar]
  • 60. Salimzadeh H., Sauvaget C., Delavari A., et al., “Colorectal Cancer Screening Pilot Project in Tehran‐Iran, a Feasibility Study,” Archives of Iranian Medicine 26, no. 3 (2023): 138–146. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61. Rahimi F., Rezayatmand R., Najafi E., Ravankhah Z., Tabesh E., and Adibi P., “Pattern of Participation in Colorectal Cancer Screening From a Population‐Based Screening Program in Iran,” Archives of Iranian Medicine 27, no. 8 (2024): 407–413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62. Rahimi F., Rezayatmand R., Shojaeenejad J., Tabesh E., Ravankhah Z., and Adibi P., “Costs and Outcomes of Colorectal Cancer Screening Program in Isfahan, Iran,” BMC Health Services Research 23, no. 1 (2023): 13. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The data produced and examined in this study can be obtained from the corresponding author upon a reasonable request, contingent upon approval from the Mashhad Regional Committee for Medical Research Ethics.


Articles from Health Science Reports are provided here courtesy of Wiley

RESOURCES